Loading insider details...
Latest Form 4 (Oct 2, 2026): Grant/Award of 3,378 RXRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 3,378 | n/a |
| Jul 2, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 3,747 | n/a |
| Jun 22, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 88,424 | n/a |
| May 7, 2026 | Merck & Co., Inc. (MRK) | Grant/Award | 19,885 | n/a |
| May 1, 2026 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 4,722 | $519.6K |
| Apr 2, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 3,268 | n/a |
| Feb 10, 2026 | Merck & Co., Inc. (MRK) | Sale | 10,235 | $1.20M |
| Feb 6, 2026 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 15,087 | $845.5K |
| Jan 28, 2026 | Merck & Co., Inc. (MRK) | Grant/Award | 20,469 | $2.20M |
| Jan 6, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 2,381 | n/a |